Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Whitfield + zinc oxide is a topical combination therapy consisting of Whitfield's solution (or ointment) and zinc oxide. Whitfield's solution contains benzoic acid and salicylic acid, both of which have antifungal and keratolytic properties. Benzoic acid acts as an antimicrobial agent that helps prevent bacterial infection, while salicylic acid promotes the shedding of rough or dead skin cells. Zinc oxide is a mineral with skin-protective, soothing, anti-inflammatory, and mild antimicrobial effects; it forms a physical barrier on the skin to protect against irritants and moisture. This combination is primarily used for treating fungal foot infections (including those caused by dermatophyte and non-dermatophyte species), as well as other minor skin irritations or conditions where both antifungal action and barrier protection are desired[1][6]. The mechanism involves direct inhibition of fungal growth (benzoic/salicylic acids) combined with physical protection/soothing from zinc oxide.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on whitfield + zinc oxide.